Klaus Frueh

Person

Portland, OR, US

People

Patents Grantslast 30 patents

Information Patent Grant
Human cytomegalovirus comprising exogenous antigens
- Patent number 11,692,012
- Issue date Jul 4, 2023
- Oregon Health & Science University
- Klaus Frueh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HIV vaccines comprising one or more population episensus antigens
- Patent number 11,628,215
- Issue date Apr 18, 2023
- Vir Biotechnology, Inc.
- Eric Bruening
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HIV vaccines comprising one or more population episensus antigens
- Patent number 11,554,168
- Issue date Jan 17, 2023
- Vir Biotechnology, Inc.
- Eric Bruening
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cytomegalovirus vectors eliciting T cells restricted by major histo...
- Patent number 11,305,015
- Issue date Apr 19, 2022
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant HCMV and RHCMV vectors and uses thereof
- Patent number 11,266,732
- Issue date Mar 8, 2022
- Oregon Health & Science University
- Louis Picker
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Methods and compositions useful in generating non canonical CD8+ T...
- Patent number 11,091,779
- Issue date Aug 17, 2021
- Oregon Health & Science University
- Klaus Frueh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human cytomegalovirus comprising exogenous antigens
- Patent number 10,995,121
- Issue date May 4, 2021
- Oregon Health & Science University
- Klaus Frueh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HIV vaccines comprising one or more population episensus antigens
- Patent number 10,894,078
- Issue date Jan 19, 2021
- Vir Biotechnology, Inc.
- Eric Bruening
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CMV vectors comprising microRNA recognition elements
- Patent number 10,688,164
- Issue date Jun 23, 2020
- Oregon Health & Science University
- Jay Nelson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytomegalovirus vectors eliciting T cells restricted by major histo...
- Patent number 10,532,099
- Issue date Jan 14, 2020
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Human cytomegalovirus comprising exogenous antigens
- Patent number 10,428,118
- Issue date Oct 1, 2019
- Oregon Health & Science University
- Klaus Frueh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cytomegalovirus vectors enabling control of T cell targeting
- Patent number 10,316,334
- Issue date Jun 11, 2019
- Oregon Health & Science University
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CMV glycoproteins and recombinant vectors
- Patent number 10,101,329
- Issue date Oct 16, 2018
- Oregon Health & Science University
- Louis Picker
- G01 - MEASURING TESTING
Information Patent Grant
Recombinant HCMV and RHCMV vectors and uses thereof
- Patent number 9,982,241
- Issue date May 29, 2018
- Oregon Health & Science University
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytomegalovirus vectors enabling control of T cell targeting
- Patent number 9,783,823
- Issue date Oct 10, 2017
- Oregon Health & Science University
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CMV glycoproteins and recombinant vectors
- Patent number 9,541,553
- Issue date Jan 10, 2017
- Oregon Health & Science University
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
siRNA useful in the treatment of flavivirus infection
- Patent number 9,328,347
- Issue date May 3, 2016
- Oregon Health & Science University
- David A. Stein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant HCMV and RHCMV vectors and uses thereof
- Patent number 9,249,427
- Issue date Feb 2, 2016
- Oregon Health & Science University
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MULTI-SPECIFIC T CELL RECEPTORS
- Publication number 20230272036
- Publication date Aug 31, 2023
- Oregon Health & Science University
- Klaus FRUEH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Cytomegalovirus Comprising Exogenous Antigens
- Publication number 20220064225
- Publication date Mar 3, 2022
- Oregon Health & Science University
- Klaus FRUEH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIV VACCINES COMPRISING ONE OR MORE POPULATION EPISENSUS ANTIGENS
- Publication number 20210046174
- Publication date Feb 18, 2021
- Vir Biotechnology, Inc.
- Eric Bruening
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIV VACCINES COMPRISING ONE OR MORE POPULATION EPISENSUS ANTIGENS
- Publication number 20210046175
- Publication date Feb 18, 2021
- Vir Biotechnology, Inc.
- Eric Bruening
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions Useful In Generating Non Canonical CD8+ T...
- Publication number 20200392534
- Publication date Dec 17, 2020
- Oregon Health & Science University
- Klaus FRUEH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CMV VECTORS COMPRISING MICRORNA RECOGNITION ELEMENTS
- Publication number 20200368333
- Publication date Nov 26, 2020
- Oregon Health & Science University
- Jay Nelson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Cytomegalovirus Vectors Eliciting T Cells Restricted By Major Histo...
- Publication number 20200237915
- Publication date Jul 30, 2020
- Oregon Health & Science University
- Louis PICKER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CYTOMEGALOVIRUS VECTORS ENABLING CONTROL OF T CELL TARGETING
- Publication number 20200140888
- Publication date May 7, 2020
- Oregon Health & Science University
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Cytomegalovirus Comprising Exogenous Antigens
- Publication number 20200102354
- Publication date Apr 2, 2020
- Klaus Frueh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT HCMV AND RHCMV VECTORS AND USES THEREOF
- Publication number 20190099479
- Publication date Apr 4, 2019
- Louis Picker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS USEFUL IN GENERATING NON CANONICAL CD8+ T...
- Publication number 20180298404
- Publication date Oct 18, 2018
- Oregon Health & Science University
- Klaus FRUEH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMAN CYTOMEGALOVIRUS COMPRISING EXOGENOUS ANTIGENS
- Publication number 20180282378
- Publication date Oct 4, 2018
- Klaus Frueh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOMEGALOVIRUS VECTORS ELICITING T CELLS RESTRICTED BY MAJOR HISTO...
- Publication number 20180133321
- Publication date May 17, 2018
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CYTOMEGALOVIRUS VECTORS ENABLING CONTROL OF T CELL TARGETING
- Publication number 20180087069
- Publication date Mar 29, 2018
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CMV GLYCOPROTEINS AND RECOMBINANT VECTORS
- Publication number 20170350887
- Publication date Dec 7, 2017
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HIV Vaccines Comprising One or More Population Episensus Antigens
- Publication number 20170319679
- Publication date Nov 9, 2017
- Vir Biotechnology, Inc.
- Eric E. BRUENING
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CMV VECTORS COMPRISING MICRORNA RECOGNITION ELEMENTS
- Publication number 20170143809
- Publication date May 25, 2017
- Oregon Health & Science University
- Jay Nelson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT HCMV AND RHCMV VECTORS AND USES THEREOF
- Publication number 20160114027
- Publication date Apr 28, 2016
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CYTOMEGALOVIRUS VECTORS ENABLING CONTROL OF T CELL TARGETING
- Publication number 20160010112
- Publication date Jan 14, 2016
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUPPRESSORS OF MATURE T CELLS
- Publication number 20140335115
- Publication date Nov 13, 2014
- Oregon Health & Science University
- Dina Alzhanova
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CMV GLYCOPROTEINS AND RECOMBINANT VECTORS
- Publication number 20140302530
- Publication date Oct 9, 2014
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SIRNA USEFUL IN THE TREATMENT OF FLAVIVIRUS INFECTION
- Publication number 20140248336
- Publication date Sep 4, 2014
- Oregon Health & Science University
- David A. Stein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS COMPRISING RECOMBINANT COWPOX VIRUS PROTEIN CPXV014
- Publication number 20130345152
- Publication date Dec 26, 2013
- Oregon Health & Science University
- Klaus Frueh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CMV GLYCOPROTEINS AND RECOMBINANT VECTORS
- Publication number 20130142823
- Publication date Jun 6, 2013
- Oregon Health & Science University
- Louis PICKER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Recombinant HCMV and RHCMV vectors and uses thereof
- Publication number 20130136768
- Publication date May 30, 2013
- Oregon Health & Science University
- Louis Picker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of treatment and diagnosis of Kaposi's sarcoma (KS) and KS...
- Publication number 20070072209
- Publication date Mar 29, 2007
- Ashlee Moses
- G01 - MEASURING TESTING
Information Patent Application
Gene expression profile for KSHV infection and methods for treating...
- Publication number 20050100891
- Publication date May 12, 2005
- Mattias Luukkonen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Gene expression profile for KSHV infection and methods for treating...
- Publication number 20030191048
- Publication date Oct 9, 2003
- Mattias Luukkonen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Klaus Frueh

Person

Patents Grantslast 30 patents

Human cytomegalovirus comprising exogenous antigens

HIV vaccines comprising one or more population episensus antigens

HIV vaccines comprising one or more population episensus antigens

Cytomegalovirus vectors eliciting T cells restricted by major histo...

Recombinant HCMV and RHCMV vectors and uses thereof

Methods and compositions useful in generating non canonical CD8+ T...

Human cytomegalovirus comprising exogenous antigens

HIV vaccines comprising one or more population episensus antigens

CMV vectors comprising microRNA recognition elements

Cytomegalovirus vectors eliciting T cells restricted by major histo...

Human cytomegalovirus comprising exogenous antigens

Cytomegalovirus vectors enabling control of T cell targeting

CMV glycoproteins and recombinant vectors

Recombinant HCMV and RHCMV vectors and uses thereof

Cytomegalovirus vectors enabling control of T cell targeting

CMV glycoproteins and recombinant vectors

siRNA useful in the treatment of flavivirus infection

Recombinant HCMV and RHCMV vectors and uses thereof

Patents Applicationslast 30 patents

MULTI-SPECIFIC T CELL RECEPTORS

Human Cytomegalovirus Comprising Exogenous Antigens

HIV VACCINES COMPRISING ONE OR MORE POPULATION EPISENSUS ANTIGENS

HIV VACCINES COMPRISING ONE OR MORE POPULATION EPISENSUS ANTIGENS

Methods and Compositions Useful In Generating Non Canonical CD8+ T...

CMV VECTORS COMPRISING MICRORNA RECOGNITION ELEMENTS

Cytomegalovirus Vectors Eliciting T Cells Restricted By Major Histo...

CYTOMEGALOVIRUS VECTORS ENABLING CONTROL OF T CELL TARGETING

Human Cytomegalovirus Comprising Exogenous Antigens

RECOMBINANT HCMV AND RHCMV VECTORS AND USES THEREOF

METHODS AND COMPOSITIONS USEFUL IN GENERATING NON CANONICAL CD8+ T...

HUMAN CYTOMEGALOVIRUS COMPRISING EXOGENOUS ANTIGENS

CYTOMEGALOVIRUS VECTORS ELICITING T CELLS RESTRICTED BY MAJOR HISTO...

CYTOMEGALOVIRUS VECTORS ENABLING CONTROL OF T CELL TARGETING

CMV GLYCOPROTEINS AND RECOMBINANT VECTORS

HIV Vaccines Comprising One or More Population Episensus Antigens

CMV VECTORS COMPRISING MICRORNA RECOGNITION ELEMENTS

RECOMBINANT HCMV AND RHCMV VECTORS AND USES THEREOF

CYTOMEGALOVIRUS VECTORS ENABLING CONTROL OF T CELL TARGETING

SUPPRESSORS OF MATURE T CELLS

CMV GLYCOPROTEINS AND RECOMBINANT VECTORS

SIRNA USEFUL IN THE TREATMENT OF FLAVIVIRUS INFECTION

COMPOSITIONS COMPRISING RECOMBINANT COWPOX VIRUS PROTEIN CPXV014

CMV GLYCOPROTEINS AND RECOMBINANT VECTORS

Recombinant HCMV and RHCMV vectors and uses thereof

Methods of treatment and diagnosis of Kaposi's sarcoma (KS) and KS...

Gene expression profile for KSHV infection and methods for treating...

Gene expression profile for KSHV infection and methods for treating...